Cochrane Abstracts
Strontium ranelate for preventing and treating postmenopausal osteoporosis
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Strontium Ranelate for Preventing and Treating Postmenopausal Osteoporosis." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/431535/0/Oral_methylxanthines_for_bronchiectasis:_Cochrane_systematic_review. Accessed 19 April 2024.
Strontium ranelate for preventing and treating postmenopausal osteoporosis. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/431535/0/Oral_methylxanthines_for_bronchiectasis:_Cochrane_systematic_review. Accessed April 19, 2024.
Strontium ranelate for preventing and treating postmenopausal osteoporosis. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/431535/0/Oral_methylxanthines_for_bronchiectasis:_Cochrane_systematic_review
Strontium Ranelate for Preventing and Treating Postmenopausal Osteoporosis [Internet]. In: Cochrane Abstracts. [cited 2024 April 19]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/431535/0/Oral_methylxanthines_for_bronchiectasis:_Cochrane_systematic_review.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Strontium ranelate for preventing and treating postmenopausal osteoporosis
ID - 431535
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/431535/0/Oral_methylxanthines_for_bronchiectasis:_Cochrane_systematic_review
DB - Evidence Central
DP - Unbound Medicine
ER -
